| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |